METHODS
The medical records of all ICU patients admitted into the intensive care unit of Oulu University Hospital with an admission diagnosis of status epilepticus during a six-year period from January 1 1998 to December 31 2003 were retrospectively reviewed. Our local ethics committee allows exemption from specific approval for retrospective medical records research. The setting was a 20-bed adult medicalsurgical ICU in a university hospital. The following data were drawn from the intensive care unit's data management system (Deio-Ohmeda ® , Helsinki, Finland): age, gender, aetiology of seizure, type of seizure, length of ICU and hospital stay (stay before ICU admission and total stay) and the use of sedative (thiopentone, propofol, midazolam) and vasoactive drugs (dopamine, noradrenaline, dobutamine), Acute Physiology and Chronic Health Evaluation (APACHE II) score, glasgow Coma Scale (gCS) score on admission, expanded therapeutic intervention severity score (TISS) 13 , outcome on hospital discharge and placement after discharge (home, another hospital).
In patients under sedative drugs the gCS score is estimated from the preadmission records.
Treatment of SE
All SE patients received routine clinical management as judged by the attending physicians. Our treatment strategy before admission into the ICU includes serial boluses of either diazepam or lorazepam and a loading dose of phosphenytoin. We defined status epilepticus as seizure activity lasting for more than five minutes or recurrent epileptic activity over a period of more than five minutes without restoration of the pre-existing level of consciousness. This time window was suggested by the operational definition of lowenstein and colleagues 14 .
Patients are admitted into our intensive care unit if anaesthetic treatment is needed (no response to first-line benzodiazepines or to second-line antiepileptic drugs), or the patient has been intubated during the prehospital treatment and mechanical ventilation is needed. After admission into the ICU, electroencephalographic (EEg) recording is started as soon as possible, but treatment is never delayed until the EEg. Twenty-four hour coverage of EEg consultation is not available in our hospital. The firstline sedative infusion for seizure control is propofol. If sufficient seizure control is not achieved, either midazolam or thiopentone is administered. The use of thiopentone, however, is limited to the management of the most severe cases. Treatment is considered successful if there is either clinical (suppression of motor manifestations) or electrical evidence of seizure control.
Classification of infections
During the daily rounds, infections were prospectively classified according to the Centers for Disease Control and Prevention (CDC) criteria 15 . An infectious disease physician has been a member of the ICU team since 1993. Infections present on admission into the ICU were classified as community-acquired (CAI), while infections that were not present or incubating at the time of hospital admission were defined as hospital-acquired infections (HAI). Infections that developed more than 48 hours after the admission to ICU were defined as ICU-acquired infections (ICUI). Pneumonia was diagnosed when a new or progressive infiltration or consolidation was found with the presence of any of the following: fever or hypothermia, leucocytosis or leucopenia, and purulent tracheal aspirate. Pneumonia developing as a consequence of gastric aspiration outside the hospital was regarded as community-acquired. Pneumonia was defined as ventilator-associated if the patient had received ventilatory therapy for at least 48 hours. Urinary tract infection was defined as a positive result on urine culture with pyuria. In the case of suspected sinusitis, a CT scan was performed. Sinusitis was then diagnosed from purulent lavage material following computed tomography evidence. Our clinical routines include daily chest X-rays and urinary cultures are analysed each time an infection is suspected. All our patients are treated in a semi-recumbent position for the prevention of ventilator-associated pneumonia.
Statistical analysis
Kruskall-Wallis and Mann-Whitney tests were used to analyse continuous data. For classified data, the Chi-Square or Fisher's exact test was utilized. The SPSS for Windows software (version 12.0, SPSS Inc., Chicago, Ill, U.S.A.) was used. Two-tailed P values are reported. The data are expressed as mean, standard deviation (SD) and range. P values lower than 0.05 were considered significant.
RESUlTS
A total of 156 patients were treated due to SE, of whom five were admitted into the ICU twice during the same episode of hospitalization, giving 161 ICU admissions. In five cases the medication history was missing. none of these five patients had an infection on admission or acquired it later during their ICU stay. Furthermore, in two other non-infected cases the hospital discharge data were missing.
The patients' mean age was 48 years (SD 17, range . The majority of patients were male (55%). The majority of cases were due to convulsive status epilepticus (140 admissions). The most common aetiological factors were pre-existing epilepsy (90/161), cerebrovascular accident (33/161) and alcohol abuse (28/161). The mean APACHE II score of the SE patients on admission was 21 (SD 7.2, range 1-43). The mean gCS score on admission was 9.2 (SD 4.8, range [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The mean total TISS was 124.0 (SD 126.5, range 4-706). During their ICU stay, the majority of patients were mechanically ventilated (97%), and 135 patients (86%) received sedative infusions for seizure control. Four patients died during their ICU treatment (2.6%) and another two patients died later in hospital, giving a mortality rate of 3.8%. Forty percent of the patients were directly discharged home from Oulu University Hospital, while the rest were transferred to another hospital.
Infection was observed in 68 (42%) of the SE patients requiring ICU treatment. Of these patients, 33 had CAI, while 35 other patients (10 HAI, 25 ICUI) acquired a nosocomial infection during their stay in hospital. The demographic data of the patients with and without infection are presented in Table 1 . The mean admission gCS scores of the patients with infections were significantly lower compared with those of the non-infected patients. The patients with CAI were more severely ill on admission (P=0.004) than those without an infection or with HAI or ICUI ( Table 2) .
All infection groups had longer ICU stays and higher nursing resource use compared to those without an infection, and the mean hospital stays of the patients with HAI and ICUI were longer than those of the patients without infection (P<0.001). Those with HAI had lower gCS scores on admission than those without infection or CAI or ICUI (P=0.003), and they had spent more time in hospital before the ICU admission. The patients with infections also received ventilator therapy and sedative drugs longer than the patients with no infection (P<0.001).
Twenty (80%) of the patients with ICUI were sedated with thiopentone compared to 20% (18/88) of those with no infection (P<0.001) ( Table 2 ). The severity of illness scores did not differ between the patients requiring thiopentone but they had significantly lower mean gCS scores on admission compared to those managed with drugs other than thiopentone (7 vs 10, P<0.001). In addition, the mean ICU length of stay was significantly longer in the patients who received thiopentone (5.9 days vs 1.8 days, P<0.0001). The patients with non-convulsive SE were more likely to have ICUI (36% vs 11%, P=0.001) than those with convulsive SE, and they also had significantly longer mean ICU stay (3.7 days vs 2.9 days, P=0.048).
Ventilator-associated pneumonia (48%) and sinusitis (20%) were the most common ICU-acquired infections, while the patients with both CAI and HAI had most commonly pneumonia (79% vs 70%) ( Table 3 ). There was documented macroscopic aspiration of gastric contents in 8 of the 26 cases of community-acquired pneumonia.
DISCUSSIOn
In this single-centre study, SE patients with infection consumed more nursing resources and stayed longer in the ICU than corresponding non-infected patients. These patients also received sedative drugs and ventilator therapy for longer periods.
This was a retrospective chart review with a relatively large population of SE patients treated in an ICU of a single centre. Our aim was to examine the overall impact of infection on the treatment course of SE patients, which question has not been addressed previously in this patient population. nosocomial infections have been studied earlier in a general neurological ICU population with a similar incidence of nosocomial infections compared to our series 12 . The frequency of ICUI, however, was lower in our series than reported earlier in a small series of SE patients (25%) 16 .
The patients with CAI had a significantly shorter hospital stay before their ICU admission and they were more severely ill than the other patients. Most of them had community-acquired pneumonia on admission into the ICU (26/33) and almost all (31/33) were treated for convulsive status epilepsy. All our patients had received first-line benzodiazepine treatment before their ICU admission. It is clear that patients with recurrent loss of consciousness and sedative drugs are at risk for aspiration. In our series, the patients with community-acquired pneumonia presented with a low level of consciousness: 80% had an ICU admission gCS less than 10, and in 31% of the cases macroscopic aspiration of gastric contents was documented in their patient charts. However, the use of sedative drugs hampers the assessment of gCS in this patient group and makes the interpretation of the scores prone to error.
It is well known that ventilator-associated pneumonia is the most frequent type of ICUI 17 . This was also true in our series. Sinusitis is also common in ICU patients with risk factors such as sedation, lowered consciousness and feeding via a nasoenteric tube 18 . Therefore, it was not surprising that 20% of the ICU-acquired infections were instances of sinusitis in our patient population, where the diagnosis of sinusitis was based on computed tomography and lavage specimens. Oral intubation was used in our patients and those requiring intubation also had a nasogastric tube in place. This incidence is, however, quite high compared to the reported frequencies of 2-7.7% in the ICU setting 18, 19 . In a large European study on the prevalence of ear, nose and throat infections in the ICU, the corresponding incidence was only 5.1% 17 . It should be noted, however, that in our series sinus CT scan was not used for screening for sinusitis in all patients, which fact may still have resulted in an underestimated frequency of sinusitis. This is supported by one study systematically searching for sinusitis in patients intubated via the nasal route and requiring prolonged mechanical ventilation. In that study, the frequency of sinusitis was as high as 40% 20 . The patients with HAI or ICUI consumed 46% of the ICU treatment days and 42% of the nursing resources as measured by TISS in this patient population. It has been shown earlier that nosocomial infections have a significant impact on hospital resource utilization 4 . Furthermore, in our series the use of thiopentone also significantly increased the length of ICU stay. Similarly, in a recent retrospective study, barbiturates tended to be associated with significantly longer hospital stay 21 . Prolonged length of stay has also been reported to be a risk factor of nosocomial infection. It is, however, often difficult to assess whether the prolonged stay is due to infection or the infection is due to the prolonged stay 17 . However, high doses of propofol with a shorter half time have recently been shown to be effective in refractory SE, leading to shorter ventilatory treatment and ICU treatment than thiopentone 22, 23 . Whether propofol also has an impact on the incidence of ICUI should be prospectively studied.
In our series, 80% of the patients with ICUI received thiopentone for seizure control. Similarly, in another study, where 10 ICU patients were treated with thiopentone, 9 patients had clinical signs of infection 23 . Thiopentone has immunosuppressive properties and may thereby predispose the patients to infectious complications 8, 9 . In our practice, however, thiopentone is used for the most severe cases where seizure control is not possible with other drugs, as suggested in the literature 5, 21 . Hence, the use of thiopentone may be a marker of the severity of the illness as well as the cause of the higher frequency of infections. Although infection appears to be related to increased use of resources and longer hospital or ICU stay, it remains open whether this is due to therapy or a surrogate marker of a need for more aggressive sedation.
In conclusion, the infection rate in status epilepticus patients is quite high and carries a cost. Furthermore, nosocomial infections prolong care and appear to be related to increased use of resources. In our series, ICUI was associated with a more frequent need of thiopentone for seizure control, which may, however, be a marker of a more severe illness and an endpoint of treatment escalation in our centre.
